Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries | Molecular Pharmacology
Understanding resistance to EGFR inhibitors—impact on future treatment strategies | Nature Reviews Clinical Oncology
EGFR blockade promotes morphological and functional rec | Open-i
Inhibiting Epidermal Growth Factor Receptor Improves Structural, Locomotor, Sensory, and Bladder Recovery from Experimental Spinal Cord Injury | Journal of Neuroscience
eGFR alto, basso e valori normali
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
EGFR signaling is critical for macrophage activation and function. (A)... | Download Scientific Diagram
Cetuximab–Polymersome–Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers | Biomacromolecules
Piezo1 activates noncanonical EGFR endocytosis and signaling | Science Advances
Cancers | Free Full-Text | Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies | Oncogene
Creatinina e funzione renale. Domande e risposte.
Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect
EGFR inhibition led ROCK activation enhances desmosome assembly and cohesion in cardiomyocytes | bioRxiv
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer | Clinical and Translational Oncology
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations | Science Signaling
The EGFR-mTOR pathway. Schematic figure displaying the molecular... | Download Scientific Diagram
Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy | Journal of Medicinal Chemistry
Frontiers | Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library
Genetic alterations shaping tumor response to anti-EGFR therapies - ScienceDirect
Full article: Synthesis, characterization and preliminary biological evaluation of chrysin amino acid derivatives that induce apoptosis and EGFR downregulation
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
